NCT07113886

Brief Summary

This study aims to enhance healing while minimizing invasiveness and restoring tissues to their proper structure and function by using patient specific sticky bone that will enhance the soft tissue reaction and maintain the graft volume stability and bone quality which stabilizes bone grafts, accelerates tissue healing, and reduces bone loss.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Aug 2025Sep 2026

First Submitted

Initial submission to the registry

August 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 11, 2025

Completed
19 days until next milestone

Study Start

First participant enrolled

August 30, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

August 11, 2025

Status Verified

August 1, 2025

Enrollment Period

1 year

First QC Date

August 3, 2025

Last Update Submit

August 3, 2025

Conditions

Keywords

ridge augmentation, horizontal bone defects, sticky bone

Outcome Measures

Primary Outcomes (2)

  • Radiographic and Histomorphometric Assessment for Guided Bone Regeneration using a Mixture of Autogenous and Xenograft Particulate Versus Patient-Specific Sticky Bone for Horizontal Anterior Maxillary Defect (Randomized Clinical Trial)

    Baseline (preoperative), 6 months postoperative for radiographic evaluation; 6 months postoperative for histomorphometric biopsy assessment at re-entry.

  • Radiographic and Histomorphometric Assessment for Guided Bone Regeneration using a Mixture of Autogenous and Xenograft Particulate Versus Patient-Specific Sticky Bone for Horizontal Anterior Maxillary Defect (Randomized Clinical Trial)

    Radiographic outcomes will include CBCT-based measurements of horizontal ridge width and bone volume gain at the grafted sites. Histomorphometric evaluation will be performed using biopsies collected at re-entry to assess new bone formation, residual graft particles, and connective tissue. Comparisons will be made between autogenous/xenograft particulate grafts and patient-specific sticky bone in terms of bone regeneration effectiveness.

    Baseline (preoperative), 6 months postoperative for radiographic evaluation; 6 months postoperative for histomorphometric biopsy assessment at re-entry.

Study Arms (2)

Autogenous + Xenograft particulate group.

ACTIVE COMPARATOR
Procedure: Mixture of Autogenous and Xenograft Particulates

Patient-specific Sticky Bone group.

EXPERIMENTAL
Procedure: Patient-Specific Sticky Bone

Interventions

This group will receive guided bone regeneration using a 1:1 mixture of autogenous bone harvested from the mandibular ramus and xenograft bone substitute (e.g., Bio-Oss). The graft material will be covered with a titanium meshes. Standard flap design, fixation, and suturing techniques will be used

Autogenous + Xenograft particulate group.

This group will receive guided bone regeneration using patient-specific sticky bone, created by mixing autogenous bone and xenograft with autologous fibrin glue (PRF). The sticky bone graft will be molded and applied directly to the defect site, covered with a titanium meshes, and stabilized using standard surgical protocol.

Patient-specific Sticky Bone group.

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients of both genders requiring implants placement in anterior maxilla with horizontal bone defect.
  • Patients of age older than 20 years old.
  • Patients with adequate Inter-arch space.
  • Patients who were willing and fully capable to comply with the study protocol.

You may not qualify if:

  • Heavy smokers (\> than 10 cigarettes a day)
  • Patients with parafunctional habits
  • Patients with uncontrolled systemic diseases.
  • Patients with poor oral hygiene
  • Patients with mental instabilities or psychic patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oral & Maxillofacial Surgery Faculty of Dentistry - Cairo University

Cairo, Egypt

Location

Study Officials

  • Ass. Prof. Dr. Mohamed Mounir Mounir Associate professor of Oral and Maxillofacial Surgery, Associate professor

    Oral & Maxillofacial Surgery Faculty of Dentistry - Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dr. Mohamed Mohsen Doctor

CONTACT

Dr. Mohsen Mohamed Nasr, BDS Oral & Dental Medicine

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Interventions 1. Preoperative preparation: History: Thorough history will be taken for all patients to identify their chief complain, medical history and dental condition. All data will be collected in the diagnostic sheet. (Appendix A) Clinical examination: • A thorough physical examination will be conducted, emphasizing the oral cavity and maxillofacial region. This includes assessing the condition of the teeth, gums, and surrounding tissues, as well as evaluating the anatomy of the maxiia . Consent: • Informed consent will be obtained from patients regarding the surgical procedure and inclusion criteria in the study Radiographic examination: • Preoperative imaging using CBCT will be performed to assess the anatomy of the maxillary bone , and the quality and quantity of bone available for grafting and to exlude the presence of any pathosis. 2. Intra operative Surgical Procedure: Phase 1: • All surgical procedures will be performed under local Anesthesia utilizing two
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DR Mohamed Mohsen Mohamed Nasr

Study Record Dates

First Submitted

August 3, 2025

First Posted

August 11, 2025

Study Start

August 30, 2025

Primary Completion (Estimated)

August 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

August 11, 2025

Record last verified: 2025-08

Locations